← Back to Search

Augmentation of Immune Response to COVID-19 mRNA Vaccination Through OMT With Lymphatic Pumps

N/A
Waitlist Available
Led By Jesus Sanchez, DO
Research Sponsored by Western University of Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if adding hands-on body treatments to COVID-19 vaccinations can boost the immune response. The study targets people receiving their vaccination at a university clinic. The treatments aim to help the immune system by improving circulation and reducing muscle tension.

Eligible Conditions
  • Coronavirus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
IgG antibody titer levels Percentage Change
IgM and IgG antibody titer duration
IgM antibody titer levels Percentage Change.
Secondary study objectives
Adverse Effects/Side Effects
Medication Usage

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: OMT Intervention ArmExperimental Treatment1 Intervention
OMT will include: 1. Myofascial release of the thoracic inlet: gentle pressure applied to shoulders and neck to move the tissue in different directions with a gentle motion. 2. Pectoral traction: The armpit will be contacted with the finger pads of the doctor and each side will be gently grasped and have a slow pulling force applied towards the shoulders. 3. Diaphragm release with MFR: The doctor will touch below the ribs on each side and will apply gentle pressure and move the tissue from side to side. 4. Splenic pump: below the ribs on the left hand-side, the doctor will apply pressure and release pressure several times to create a vibration over the area just below the ribs. 5. Thoracic pump: The doctor will place their hands over the chest wall on each side and will apply pressure and release pressure several times to generate a pumping action of about 100 times in one minute. Treatment will last 5 minutes with each technique lasting 1 minute.
Group II: ControlActive Control1 Intervention
Participants in the control group will undergo the same assessments as the OMT intervention arm and will receive their vaccinations, but will not receive any OMT.

Find a Location

Who is running the clinical trial?

Western University of Health SciencesLead Sponsor
24 Previous Clinical Trials
1,237 Total Patients Enrolled
American College of Osteopathic PhysiciansUNKNOWN
American Osteopathic FoundationUNKNOWN
2 Previous Clinical Trials
50 Total Patients Enrolled
Osteopathic Physicians and Surgeons of CaliforniaUNKNOWN
Xavier-Nichols FoundationUNKNOWN
Jesus Sanchez, DO4.04 ReviewsPrincipal Investigator - Professor of Family Medicine
Western University of Health Sciences
~20 spots leftby Dec 2025